Sandeep Laumas - 12 Jul 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role: Director
Signature: /s/ Sandeep Laumas
Issuer symbol: UNCY
Transactions as of: 12 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 12 Jul 2021, 17:12:31 UTC
Previous filing: 15 Jun 2021
Next filing: 11 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	UNCY	Common Stock						48,838	12 Jul 2021	Direct
holding	UNCY	Common Stock						56,977	12 Jul 2021	By Hilbert8 Investments LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	UNCY	Employee Stock Option (right to buy)							12 Jul 2021	Common Stock	11,628	$0.0100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the stock options vested on August 1, 2019, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on August 1, 2022.